PBS Website Update - 1 December 2021
Page last updated: 1 December 2021
The Schedule of Pharmaceutical Benefits was updated on 1 December 2021 and the Summary of Changes can be found on the New, Amended and Deleted Items page.
The following updates have also been made to the PBS Website.
- Drugs subject to Price Disclosure - 1 December 2021
- Ex-manufacturer price - 1 December 2021
- First New Brand Price Reductions - 1 December 2021
- Formulary Allocations - 1 December 2021
- Section 19A medicines subsidised by the Pharmaceutical Benefits Scheme - 1 December 2021
- Medicine Status Website
- Updated 2021 – 22 Cost Recovery Implementation Statement - 30 November 2021
- PBAC Meeting Agenda and Consumer Comments - 29 November 2021
- PBAC Stakeholder Meetings - 24 November 2021
- March 2022 PBAC Meeting - 24 November 2021
- Semaglutide (Wegovy®) Stakeholder Meeting Outcome Statement - 24 November 2021
- Drug Utilisation Sub Committee (DUSC) - 24 November 2021
- Ministerial Discretion not to apply Statutory Price Reductions - 19 November 2021
- Five Year Anniversary 5% Price Reduction - List of Affected Drugs - 18 November 2021
- PBS and RPBS Section 85 Date of Supply Data - 16 November 2021
- The Public Summary Documents (first time rejections and deferrals) – July 2021 meeting - 12 November 2021
- Health Products Portal Industry Webinars - 12 November 2021
- Progress update: Post-market Review (PMR) of medicines for smoking cessation - 12 November 2021
- Pharmaceutical Benefits Scheme Continued Dispensing Arrangements - 5 November 2021
- Drug Utilisation Sub-Committee (DUSC) Utilisation Analysis Public Release Documents - 5 November 2021
- Drug Utilisation Sub-Committee (DUSC) Outcome Statement - 5 November 2021
